Cambridge Investment Research Advisors’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EDVA Stock Details EDVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-326	Closed	-$8K	–	3613
2024 Q4	$8K	Hold	326	–	–	﹤0.01%	3446
2024 Q3	$13K	Hold	326	–	–	﹤0.01%	3386
2024 Q2	$12K	Buy	326 +1	+0.3%	+$47	﹤0.01%	3285
2024 Q1	$24K	Hold	325	–	–	﹤0.01%	3256
2023 Q4	$29K	Sell	325 -101	-24%	-$9.62K	﹤0.01%	3130
2023 Q3	$40K	Hold	426	–	–	﹤0.01%	3054
2023 Q2	$76K	Buy	426 +274	+180%	+$50.1K	﹤0.01%	3042
2023 Q1	$40K	Hold	152	–	–	﹤0.01%	3062
2022 Q4	$23K	Hold	152	–	–	﹤0.01%	3034
2022 Q3	$33K	Hold	152	–	–	﹤0.01%	2971
2022 Q2	$73K	Buy	+152	New	+$54.9K	﹤0.01%	2902

Other funds holding EDVA

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Investment Research Advisors's EDVA Position: Q1 2025 in Review

Cambridge Investment Research Advisors sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 326 shares — an estimated $8K sold.

Cambridge Investment Research Advisors first reported a position in EDVA in Q2 2022 and held it in 11 quarters. The position peaked at $76K in Q2 2023. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

Cambridge Investment Research Advisors reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
Cambridge Investment Research Advisors sold 326 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $8K.
Cambridge Investment Research Advisors first reported a position in Endovia Health Sciences, Inc. in Q2 2022 and held it in 11 quarters.
Cambridge Investment Research Advisors's Endovia Health Sciences, Inc. position peaked at $76K in Q2 2023.
11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.